APA (7th ed.) Citation

V, V., M, C., C, M., J, B., EE, B., E, G., . . . E, T. (2026). Production and characterization of rNGFSP: A recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease. Biotechnology reports (Amsterdam, Netherlands), 49, e00946. https://doi.org/10.1016/j.btre.2026.e00946

Chicago Style (17th ed.) Citation

V, Varela, et al. "Production and Characterization of RNGFSP: A Recombinant Fusion Immunogen Eliciting Dual Anti-NGF and Anti-Substance P Therapeutic Antibodies for Degenerative Joint Disease." Biotechnology Reports (Amsterdam, Netherlands) 49 (2026): e00946. https://doi.org/10.1016/j.btre.2026.e00946.

MLA (9th ed.) Citation

V, Varela, et al. "Production and Characterization of RNGFSP: A Recombinant Fusion Immunogen Eliciting Dual Anti-NGF and Anti-Substance P Therapeutic Antibodies for Degenerative Joint Disease." Biotechnology Reports (Amsterdam, Netherlands), vol. 49, 2026, p. e00946, https://doi.org/10.1016/j.btre.2026.e00946.